Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 65 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 7687610

    Human chorionic gonadotropin superagonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  2. US 7683095

    Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  3. US 7678569

    Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  4. US 7674777

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  5. US 7670806

    ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  6. US 7666846

    Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  7. US 7666411

    Methods of treating and preventing colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  8. US 7662395

    Method of enhancing a targeted immune response against tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  9. US 7662394

    Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  10. US 7662397

    Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  11. US 7662573

    Methods for evaluating osteoarthritis risk

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  12. US 7662592

    Bacteriocin inducer peptides

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  13. US 7658364

    Ocular therapeutic agent delivery devices and methods for making and using such devices

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  14. US 7655694

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  15. US 7655397

    Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  16. US 7641906

    Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted
  17. US 7641909

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted
  18. US 7635485

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted
  19. US 7635688

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted
  20. US 7635486

    Recombinant lipidated PsaA protein, methods of preparation and use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted
  21. US 7625736

    Methods for preparing immunogenic conjugates

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted
  22. US 7622123

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  23. US 7622113

    Monoclonal antibodies that bind or neutralize dengue virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  24. US 7622272

    Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted